Potential Iatrogenic Harms From Medicinal Cannabis Prescribing in Australia: A Case Series
Richard Bradlow, James Sorensen, Anna Cunningham, Sean Daugherty, Eric Hadinata, Ferghal Armstrong, Nazila Jamshidi · 2026
Read Potential Iatrogenic Harms From Medicinal Cannabis Prescribing in Australia: A Case Series by Richard Bradlow, James Sorensen, Anna Cunningham, Sean Daugherty, Eric Hadinata, Ferghal Armstrong, Nazila Jamshidi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13530416.txt.
Description
Medicinal cannabis prescribing has boomed in Australia, including for mental illness where the evidence is thin, and Richard Bradlow and co-authors present three cautionary cases. The patients were young men in their early twenties, each with a psychiatric disorder and a history of substance vulnerability, each prescribed cannabis through the current system.
The harms that followed included a vomiting syndrome caused by cannabis, cannabis use disorder, paranoia, and unstable mood, plus delays to other treatment. In two cases the prescribing continued even after harms appeared — in one, despite an addiction specialist's formal request to stop. The authors call for prescribing that matches the evidence, clearer exclusion rules, and a quicker trigger to stop when harm emerges, above all for commercially driven models of care.
Catalog record
| CREATOR | Richard Bradlow, James Sorensen, Anna Cunningham, Sean Daugherty, Eric Hadinata, Ferghal Armstrong, Nazila Jamshidi |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 15 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |